President Joe Biden last week explained how he would like Congress to control drug prices, but he gave leeway on policies that Democrats are expected to have a difficult time negotiating among themselves. Biden said Medicare negotiators should be provided a framework for determining “fair” prices -- compared to industry’s emphasis on drug “value.” That’s a hint that the White House wants an aggressive approach to controlling drug prices, a policy researcher monitoring the debate said. Value often implies prices...